Overview of JAK-inhibitors

in Australian clinical practice


Hear from three of Australia's top rheumatologists A/Prof Östör, Dr Tellus and A/Prof Bird in this videocast-style learning activity.

Learning outcomes

By the end of this activity, participants will be able to:

  • Describe what a JAK-inhibitor is and where they fit into current therapy
  • Describe the benefits of available JAK-inhibitors over standard care
  • Identify and manage common adverse events associated with JAK-inhibitors.


This activity has been designed to take 1 hour to complete and is suitable for 1 Category 1 Credit in the RACP’s MyCPD programme.

Other healthcare professionals can still enrol and complete this course. You will receive a certificate upon completion.


If you do not already have an account with Arterial Education, you will be required to create one. This verifies that you are a healthcare professional and allows you to log your learning activities.